Axcelis Technologies (NASDAQ:ACLS) Shares Gap Up – Should You Buy?

Posted by Geri Gentry on Oct 2nd, 2026

Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) shares gapped up prior to trading on Friday. The stock had previously closed at $136.71, but opened at $143.27. Axcelis Technologies shares last traded at $145.5490, with a volume of 69,268 shares traded.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ACLS. Weiss Ratings restated a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Friday, August 7th. Craig Hallum lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price objective on the stock. in a research note on Friday, August 7th. Finally, Bank of America lifted their price objective on shares of Axcelis Technologies from $130.00 to $156.00 and gave the company an “underperform” rating in a report on Tuesday, June 23rd. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $148.67.

View Our Latest Stock Report on Axcelis Technologies

Axcelis Technologies Stock Up 7.5%

The company has a current ratio of 4.90, a quick ratio of 3.21 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $4.54 billion, a P/E ratio of 49.40, a P/E/G ratio of 4.01 and a beta of 1.85. The stock’s 50-day simple moving average is $123.32 and its 200-day simple moving average is $134.00.

Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last posted its earnings results on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The firm had revenue of $215.18 million for the quarter, compared to analysts’ expectations of $205.03 million. During the same quarter last year, the firm earned $1.13 EPS. The company’s quarterly revenue was up 10.6% compared to the same quarter last year. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. As a group, research analysts predict that Axcelis Technologies, Inc. will post 3.39 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of ACLS. The Manufacturers Life Insurance Company lifted its stake in Axcelis Technologies by 3,402.5% in the first quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock valued at $45,772,000 after purchasing an additional 477,705 shares during the last quarter. Wellington Management Group LLP bought a new position in Axcelis Technologies during the second quarter valued at $13,070,000. Peterson Wealth Services increased its position in Axcelis Technologies by 1,750.8% in the fourth quarter. Peterson Wealth Services now owns 7,403 shares of the semiconductor company’s stock worth $595,000 after buying an additional 7,003 shares during the last quarter. Entropy Technologies LP purchased a new stake in Axcelis Technologies in the first quarter worth $1,004,000. Finally, Segall Bryant & Hamill LLC raised its stake in shares of Axcelis Technologies by 96.1% in the first quarter. Segall Bryant & Hamill LLC now owns 200,371 shares of the semiconductor company’s stock valued at $18,651,000 after buying an additional 98,184 shares during the period. Institutional investors own 89.98% of the company’s stock.

About Axcelis Technologies

(Get Free Report)

Axcelis Technologies, Inc (NASDAQ: ACLS) develops and manufactures equipment used in semiconductor fabrication. The company’s primary business is ion implantation, a process that modifies the electrical properties of silicon and other semiconductor materials by introducing controlled amounts of dopants. Its systems are used by chip manufacturers to produce a range of semiconductor devices.

Axcelis offers the Purion family of ion implantation systems, including platforms designed for high-current, medium-current and high-energy applications.